Hữu Vĩnh Vũ

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial

Roy S. Herbst, Yi‐Long Wu, Thomas John et al. · Journal of Clinical Oncology · 2023 · 350 citations · Full text

Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC

Yi‐Long Wu, Thomas John, Christian Grohé et al. · Journal of Thoracic Oncology · 2021 · 148 citations · Full text

The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.

M T Lotze, Beth A. Hellerstedt, L. A. Stolinski et al. · PubMed · 1997 · 69 citations

Efficacy of Microwave Ablation in the Treatment of Large (≥3 cm) Benign Thyroid Nodules

Huynh Quang Khanh, Ngo Quoc Hung, Hữu Vĩnh Vũ et al. · World Journal of Surgery · 2020 · 27 citations

LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA

Masahiro Tsuboi, Yi‐Long Wu, C Grohé et al. · Annals of Oncology · 2022 · 23 citations

Surgical Oncology, Medicine, Lba47 Osimertinib +8